Emil Parente, 88 years old, is a WMer with a real past, and he is happy to share it with others, particularly those who are newly diagnosed.
The IWMF Board of Trustees announces funding for two new IWMF-LLS Strategic Research Roadmap projects and for ongoing research by Dr. Steven Treon and Dr. Stephen Ansell.
Registration is still available to attend the October 13-14 International Patient Conference on WM, and to hear presentations from leading worldwide researchers
The IWMF is invited to participate in the LLS’s new effort to collect data from electronic medical records for patients seen in the US. In just a few steps, your data can be on its way!
The IWMF is pleased to announce that the U.S. FDA has approved the combination treatment of Imbruvica (ibrutinib) together with Rituximab (rituxan) for the treatment of WM.
Tom Hoffmann, MD, is the newest member of the Board of Trustees. His medical background and knowledge of WM will be of great benefit to the IWMF community.
Video for IWMF Website Visitors – Introducing the IWMF and its Services
Diagnosed with WM in 2015 at the age of 70, in 2016 he published two books of poetry, he is writing his third book and has two more in mind. ...
Cure Magazine recently published their Rare Cancers Special Issue, which contains an article focused specifically on WM and recent treatment advances for it.
Bob Rupert discusses how WM has affected him and his family and how he is living with the disease.